MARKET

LFVN

LFVN

LifeVantage
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.39
+0.02
+0.15%
Closed 16:00 08/12 EDT
OPEN
13.42
PREV CLOSE
13.37
HIGH
13.55
LOW
13.00
VOLUME
45.97K
TURNOVER
--
52 WEEK HIGH
17.25
52 WEEK LOW
7.75
MARKET CAP
191.65M
P/E (TTM)
17.04
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average LFVN stock price target is 20.00 with a high estimate of 20.00 and a low estimate of 20.00.

EPS

LFVN News

More
LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2020 Results on August 18, 2020
SALT LAKE CITY, Aug. 04, 2020 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2020, after the stock market closes on Tuesday, August 18,
GlobeNewswire · 08/04 12:00
Should You Buy Lifevantage Corporation (LFVN)?
In this article we will take a look at whether hedge funds think Lifevantage Corporation (NASDAQ:LFVN) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of d
Insider Monkey · 06/24 01:18
Calculating The Fair Value Of LifeVantage Corporation (NASDAQ:LFVN)
Simply Wall St. · 05/26 20:50
LifeVantage's (LFVN) CEO Darren Jensen on Q3 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/06 01:14
Lifevantage Q3 EPS $0.130 Misses $0.160 Estimate, Sales $56.000M Miss $60.700M Estimate
Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.130 per share which missed the analyst consensus estimate of $0.160 by 18.75 percent. This is unchanged from the same period last year. The company reported
Benzinga · 05/05 20:23
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2020
Third Quarter Revenue of $56 million Third Quarter Adjusted EBITDA Increased 26% Year over Year Reiterates Fiscal 2020 Adjusted Earnings Per Share and EBITDA Guidance SALT.
GlobeNewswire · 05/05 20:05
What Is LifeVantage's (NASDAQ:LFVN) P/E Ratio After Its Share Price Rocketed?
Simply Wall St. · 05/04 12:22
LifeVantage to Announce Third Quarter Fiscal Year 2020 Results on May 5, 2020
GlobeNewswire · 04/15 20:05

Industry

Pharmaceuticals
+2.16%
Pharmaceuticals & Medical Research
+1.79%

Hot Stocks

Symbol
Price
%Change

About LFVN

LifeVantage Corporation is focused on bio-hacking the aging code through nutrigenomics. The Company is helping people their health, wellness and financial independence goals. The Company is engaged in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim Nrf2 synergizer, Protandim NRF1 synergizer, LifeVantage TrueScience, Petandim for dogs, and Axio. It sells products in the United States, Japan, Hong Kong, Australia, Canada, Mexico, Thailand, the United Kingdom, the Netherlands and Germany.
More

Webull offers kinds of LifeVantage Corp stock information, including NASDAQ:LFVN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LFVN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LFVN stock methods without spending real money on the virtual paper trading platform.